Xellia North America

Xellia North America is owned by Xellia. Xellia has a direct presence in 2 countries.

View the org chart displaying its 3 main executives

Most searched biographies at Xellia North America

• Craig Boyd, President
• Michael Fiocco, Generics Franchise Lead
• Peter Baker, Chief Commercial Officer

Create your alert
to follow the executive moves at Xellia North America.

Xellia has 1,865 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Xellia North America

Social media about Xellia North America

• Xellia North America on Wikipedia, Google News & Yahoo Finance
• Xellia North America on LinkedIn, Twitter & YouTube

Contact by email its executives including Craig Boyd

Call Xellia North America at +1 847...

View the org chart

Register to receive your alert

Report an error